Kamyar Kalantar-Zadeh

Medicine/Nephrology, Harbor-UCLA, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Dialysis & Renal Transplantation (since 26 February 2008)

All recent recommendations

• 8.6
  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
  Recommended by Kamyar Kalantar-Zadeh, Jurg Schifferli with Michael Mayr, Kenneth White with Emily G Farrow, Bradley Dixon, Csaba Kovesdy, Alan Yu with Jeanie Park
  
• 3.0
  High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death.
  Recommended by Kamyar Kalantar-Zadeh
  
• 6.0
  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.
  Recommended by Kamyar Kalantar-Zadeh
  
• 3.0
  K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
  Recommended by Kamyar Kalantar-Zadeh with Csaba P Kovesdy